Associated Papers
Prevalence and types of genetic polymorphisms of CYP2C19 and their effects on platelet aggregation inhibition by clopidogrel.
Aga QAA et al.
European Review for Medical and Pharmacological Sciences, 2020
Clinical pharmacokinetics and pharmacodynamics of clopidogrel.
Jiang XL et al.
Clinical Pharmacokinetics, 2015
Pharmacogenomics of clopidogrel: evidence and perspectives.
Yin T et al.
Thrombosis Research, 2011
Genotyping: one piece of the puzzle to personalize antiplatelet therapy.
Gurbel PA et al.
Journal of the American College of Cardiology, 2010
Select a paper to view details